An Update on Dual-Energy X-Ray Absorptiometry

Seminars in Nuclear Medicine

Volumn 40, Issue 1, 2010, Pages 62-73

  Blake, Glen M ^a   Fogelman, Ignac ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; ZOLEDRONIC ACID;

ACCURACY; BONE DENSITOMETRY; BONE DENSITY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE TREATMENT; FRAGILITY FRACTURE; HIP; HUMAN; MEDICAL DECISION MAKING; OSTEOPENIA; PHYSICAL EXAMINATION; PREDICTION; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPINE; SPINE FRACTURE; TREATMENT RESPONSE; ULTRASOUND; VERTEBRA FRACTURE; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; FRACTURES, BONE; HUMANS; RISK ASSESSMENT; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 70549104905     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2009.08.001     Document Type: Review

References (93)

1. Cummings S.R., and Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1767
2. Kanis J.A., Black D., Cooper C., et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13 (2002) 527-536
3. National Osteoporosis Foundation. Fast facts on osteoporosis. http://www.nof.org/professionals/Clinicians_Guide.htm Accessed February 20, 2009
4. Dolan P., and Torgerson D.J. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8 (1998) 611-617
5. Melton L.J., Gabriel S.E., Crowson C.S., et al. Cost-equivalence of different osteoporotic fractures. Osteoporos Int 14 (2003) 383-388
6. Cooper C., Atkinson E.J., Jacobsen S.J., et al. Population based study of survival after osteoporotic fractures. Am J Epidemiol 137 (1993) 1001-1005
7. Centre J.R., Nguyen T.V., Schneider D., et al. Mortality after all major types of osteoporotic fractures in men and women: an observational study. Lancet 353 (1999) 878-882
8. Genant H.K., Engelke K., Fuerst T., et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11 (1996) 707-730
9. Storm T., Thamsborg G., Steiniche T., et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322 (1990) 1265-1271
10. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: technical report series 843 (1994), WHO, Geneva, Switzerland
11. Kanis J.A., Gluer C.C., and Committee of scientific advisors. International Osteoporosis Foundation: an update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11 (2000) 192-202
12. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348 (1996) 1535-1541
13. Cummings S.R., Black D.M., Thompson D.E., et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280 (1998) 2077-2082
14. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. JAMA 282 (1999) 1344-1352
15. McClung M.R., Geusens P., Miller P.D., et al. Effect of risedronate treatment on hip fracture risk in elderly women. N Engl J Med 344 (2001) 333-340
16. Chesnut C.H., Skag A., Christiansen C., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19 (2004) 1241-1249
17. Black D.M., Delmas P.D., Eastell R., et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356 (2007) 1809-1822
18. Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. JAMA 282 (1999) 637-645
19. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of recombinant human parathyroid hormone (1-34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N Engl J Med 344 (2001) 1434-1441
20. Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
21. Reginster J.Y., Seeman E., De Vernejoul M.C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: TROPOS study. J Clin Endocrinol Metab 90 (2005) 2816-2822
22. Seeman E., Vellas B., Benhamou C., et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21 (2006) 1113-1120
23. FRAX-WHO Fracture Risk Assessment Tool. http://www.shef.ac.uk/FRAX Accessed February 20, 2009
24. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
25. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/index.htm Accessed February 20, 2009
26. Kanis J.A., Johnell O., Oden A., et al. FRAX and the assessment of facture probability in men and women from the UK. Osteoporos Int 19 (2008) 385-397
27. Kanis J.A., McCloskey E.V., Johansson H., et al. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 19 (2008) 1395-1408
28. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8 (1998) 468-489
29. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
30. Stone K.L., Seeley D.G., Lui L.Y., et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18 (2003) 1947-1954
31. Johnell O., Kanis J.A., Oden A., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 20 (2005) 1185-1194
32. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 338 (1998) 736-746
33. Gluer C.C. Monitoring skeletal change by radiological techniques. J Bone Miner Res 14 (1999) 1952-1962
34. Official positions of the International Society for Clinical Densitometry: updated 2007. http://www.iscd.org/visitors/positions/official.cfm Accessed February 20, 2009
35. Adams J.E., Ahmed S.F., Alsop C., et al. A Practical Guide to Bone Densitometry in Children (2004), National Osteoporosis Society, Bath, UK
36. Ward K.A., Ashby R.L., Roberts S.A., et al. UK reference data for the Hologic QDR Discovery dual-energy x-ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch Dis Child 92 (2007) 53-59
37. Blake G.M., and Fogelman I. Technical principles of dual-energy x-ray absorptiometry. Semin Nucl Med 27 (1997) 210-228
38. Lehmann L.A., Alvaez R.E., Macovski A., et al. Generalized image combinations in dual KVP digital radiography. Med Phys 8 (1981) 659-667
39. Webber C.E. The effect of fat on bone mineral measurements in normal subjects with recommended values of bone, muscle and fat attenuation coefficients. Clin Phys Physiol Meas 8 (1987) 143-157
40. Svendsen O.L., Hassager C., Skodt V., et al. Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip and forearm: a human cadaver study. J Bone Miner Res 10 (1995) 868-873
41. Kuiper J.W., van Kuijk C., Grashusi J.L., et al. Accuracy and the influence of marrow fat on quantitative CT and dual-energy x-ray absorptiometry measurements of the femoral neck in vitro. Osteoporos Int 6 (1996) 25-30
42. Blake G.M., and Fogelman I. How important are BMD accuracy errors for the clinical interpretation of DXA scans?. J Bone Miner Res 23 (2008) 457-462
43. Bonnick S.L., Johnston Jr. C.C., Kleerekoper M., et al. Importance of precision in bone density measurements. J Clin Densitom 4 (2001) 105-110
44. Gluer C.C., Blake G., Lu Y., et al. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5 (1995) 262-270
45. Patel R., Blake G.M., Rymer J., et al. Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11 (2000) 68-75
46. Tothill P., and Pye D.W. Errors due to non-uniform distribution of fat in dual x-ray absorptiometry of the lumbar spine. Br J Radiol 65 (1992) 807-813
47. Griffith J.F., Yeung D.K., Antonio G.E., et al. Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241 (2006) 831-838
48. Wahner H.W., Dunn W.L., Mazess R.B., et al. Dual photon Gd-153 absorptiometry of bone. Radiology 156 (1985) 203-206
49. Eriksson S., Isberg B., and Lindgren U. Vertebral bone mineral measurement using dual photon absorptiometry and computed tomography. Acta Radiol 29 (1988) 89-94
50. Gotfredsen A., Podenphant J., Norgaard H., et al. Accuracy of lumbar spine bone mineral content by dual photon absorptiometry. J Nucl Med 29 (1988) 248-254
51. Ho C.P., Kim R.W., Schaffler M.B., et al. Accuracy of dual-energy radiography of the lumbar spine: a cadaver study. Radiology 176 (1990) 171-173
52. Sabin M.A., Blake G.M., MacLaughlin-Black S.M., et al. The accuracy of volumetric bone density measurements in dual X-ray absorptiometry. Calcif Tiss Int 56 (1995) 210-214
53. Tothill P., Pye D.W., and Teper J. The influence of extra-skeletal fat on the accuracy of dual photon absorptiometry of the spine. In: Ring E.F.J., Evans W.D., and Dixon A.S. (Eds). Osteoporosis and Bone Mineral Measurement (1989), ISPM, York, United Kingdom 48-53
54. Lee D.C., Wren T.A.L., and Gilanz V. Correcting DXA pediatric bone mineral density measurements to account for fat inhomogeneity. J Bone Miner Res 22 suppl 1 (2007) S494-S495
55. Fogeman I., and Blake G.M. Different approaches to bone densitometry. J Nucl Med 41 (2000) 2015-2025
56. Guglielmi G., and Lang T.F. Quantitative computed tomography. Semin Musculoskelet Radiol 6 (2002) 219-227
57. Lang T.F., Guglielmi G., Van Kuijk C., et al. Measurement of vertebral bone mineral density at the spine and proximal femur by volumetric quantitative computed tomograph and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30 (2002) 247-250
58. Blake G.M., and Fogelman I. Clinical use of instruments that measure peripheral bone mass. Curr Opin Endocrinol Diabetes 9 (2002) 502-511
59. Stewart A., and Reid D.M. Quantitative ultrasound in osteoporosis. Semin Musculoskelet Radiol 6 (2002) 229-232
60. Lu Y., Genant H.K., Shepherd J., et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res 16 (2001) 901-910
61. Faulkner K.G., Von Stetton E., and Miller P. Discordance in patient classification using T-scores. J Clin Densitom 2 (1999) 343-350
62. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. Lancet 341 (1993) 72-75
63. Blake G.M., and Fogelman I. Peripheral or central densitometry: does it matter which technique we use?. J Clin Densitom 4 (2001) 83-96
64. Black D.M., Palermo L., and Bauer D. How well does bone mass predict long-term risk of hip fracture?. Osteoporos Int 11 suppl 2 (2000) S59
65. Barr R.J., Adebajo A., Fraser W.D., et al. Can peripheral DXA measurements be used to predict fractures in elderly women living in the community?. Osteoporos Int 16 (2005) 1177-1183
66. Faulkner K.G., Roberts L.A., and McClung M.R. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int 6 (1996) 432-436
67. Hanson J. Standardization of femur BMD. J Bone Miner Res 12 (1997) 1316-1317
68. Blake G.M., Chinn D.J., Steel S.A., et al. A list of device specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int 16 (2005) 2149-2156
69. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 (2002) 1929-1936
70. De Laet C., Oden A., Johansson H., et al. The impact of the use of multiple risk factors for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16 (2005) 313-318
71. Kanis J.A., Johnell O., Oden A., et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12 (2001) 989-995
72. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046
73. Kanis J.A., Johnell O., De Laet C., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 (2004) 375-382
74. Kanis J.A., Johansson H., Oden A., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 (2004) 893-899
75. Kanis J.A., Johansson H., Oden A., et al. A family history of fracture and fracture risk: a meta-analysis. Bone 35 (2004) 1029-1037
76. Kanis J.A., Johnell O., Oden A., et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 16 (2005) 155-162
77. Kanis J.A., Johansson H., Johnell O., et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 16 (2005) 737-742
78. De Laet C., Kanis J.A., Oden A., et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16 (2005) 1330-1338
79. Kanis J.A., Johnell O., Oden A., et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int 17 (2006) 527-534
80. Blake G.M., Patel R., Knapp K.M., et al. Does the combination of two BMD measurements improve fracture discrimination?. J Bone Miner Res 18 (2003) 1955-1963
81. Fink H.A., Harrison S.L., Taylor B.C., et al. Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures. J Clin Densitom 11 (2008) 250-259
82. Johansson H., Oden A., Johnell O., et al. Optimisation of BMD measurements to identify high risk groups for treatment-a test analysis. J Bone Miner Res 19 (2004) 906-913
83. National Osteoporosis Guideline Group. http://www.shef.ac.uk/NOGG/index.html Accessed February 20, 2009
84. Kanis J.A., Oden A., Johnell O., et al. The burden of osteoporotic fractures: a method of setting intervention thresholds. Osteoporos Int 12 (2001) 417-427
85. Borgstrom F., Johnell O., Kanis J.A., et al. At what hip fracture risk is it cost effective to treat?. International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17 (2006) 1459-1471
86. Kanis J.A., Borgstrom F., Zethraeus N., et al. Intervention thresholds for osteoporosis in the UK. Bone 36 (2005) 22-32
87. Zethraeus N., Borgstrom F., Strom O., et al. Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 18 (2007) 9-23
88. Kanis J.A., Borgstrom F., Johnell O., et al. Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporos Int 16 (2005) 15-25
89. Borgstrom F., Carisson A., Sintonen H., et al. Cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporos Int 17 (2006) 996-1007
90. Borgstrom F., Jonsson B., Strom O., et al. An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting based on the results of the SOTI and TROPOS trials. Osteoporos Int 17 (2006) 1781-1793
91. Faulkner K.G. Bone densitometry: choosing the proper site to measure. J Clin Densitom 1 (1998) 279-285
92. Blake G.M., Herd R.J.M., and Fogelman I. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporos Int 6 (1996) 462-470
93. Blake G.M. Scientific flaws of the WHO T-score definition of osteoporosis. J Clin Densitom 11 (2008) 450-451